Viewing data from:

METOCLOPRAMIDE HYDROCHLORIDE

ANDA

METOCLOPRAMIDE HYDROCHLORIDE | A078807 | IPCA LABORATORIES LTD

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: REGLAN(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 5 NDCs

Highest NADAC/Unit

$0.0446

per ea

Lowest NADAC/Unit

$0.0371

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
83980001101METOCLOPRAMIDE 10 MG TABLET	$0.0446	EA	Generic	—	2026-06-17
83980001105METOCLOPRAMIDE 10 MG TABLET	$0.0446	EA	Generic	—	2026-06-17
83980001110METOCLOPRAMIDE 10 MG TABLET	$0.0446	EA	Generic	—	2026-06-17
83980001001METOCLOPRAMIDE 5 MG TABLET	$0.0371	EA	Generic	—	2026-06-17
83980001005METOCLOPRAMIDE 5 MG TABLET	$0.0371	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain3 active DMFs5 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

COSMA SPAMETOCLOPRAMIDE HYDROCHLORIDE

DMF 45231982

LIAOYUAN SILVER EAGLE PHARMACEUTICAL CO LTDMETOCLOPRAMIDE HYDROCHLORIDE

DMF 289872014

EMCURE PHARMACEUTICALS LTDMETOCLOPRAMIDE HYDROCHLORIDE USP

DMF 329912018

DINAMITE DIPHARMA SPAInactiveMETOCLOPRAMIDE HYDROCHLORIDE BP'80

DMF 43811981

ORGAMOL SAInactiveMETOCLOPRAMIDE

DMF 58131985

BOEHRINGER INGELHEIM CHEMICALS INCInactiveMETOCLOPRAMIDE

DMF 60701985

MEDICHEM SAInactiveMETOCLOPRAMIDE HYDROCHLORIDE

DMF 62391986

BENZOCHEM LIFESCIENCES PVT LTDInactiveMETOCLOPRAMIDE HYDROCHLORIDE USP

DMF 212712008

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — EQ 5MG BASE

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jun 12, 2008

No patent or exclusivity listings for this strength.

#002 — EQ 10MG BASE

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jun 12, 2008